A predictor of response in HER2+ breast cancer-at last!

Subjects

Subjects :

Humans
Female
Trastuzumab therapeutic use
Receptor, ErbB-2
Neoadjuvant Therapy
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms genetics
Breast Neoplasms drug therapy

Details

Language :

English

ISSN :

1460-2105

Volume :

115

Issue :

3

Database :

MEDLINE

Journal :

Journal of the National Cancer Institute

Publication Type :

Report

Accession number :

36576003

Full Text :

https://doi.org/10.1093/jnci/djac228